New Approach to Treating “Type 3 Diabetes”

MSDC_alzheimers_WebICONAlzheimer’s disease has been characterized as “type 3 diabetes.” Insulin sensitizers may play a role in treating Alzheimer’s disease and MSDC has developed a new insulin sensitizer that may prevent cognitive decline in people with Alzheimer’s-related dementia.

Read more...